FDA Inspection 803415 — Radnostix

Radnostix — FEI 3003350319

The FDA completed an inspection of Radnostix on Oct 19, 2012 in Idaho Falls, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 19, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Idaho Falls, ID (United States)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
177421 CFR 211.142(a)Quarantine - actual practice
191421 CFR 211.166(a)Lack of written stability program
431421 CFR 211.84(d)(2)Reports of Analysis (Components)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.